0001104659-24-072817.txt : 20240618 0001104659-24-072817.hdr.sgml : 20240618 20240618161539 ACCESSION NUMBER: 0001104659-24-072817 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240614 FILED AS OF DATE: 20240618 DATE AS OF CHANGE: 20240618 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Calais Philippe CENTRAL INDEX KEY: 0001693728 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40363 FILM NUMBER: 241051976 MAIL ADDRESS: STREET 1: C/O MARINA BIOTECH, INC. STREET 2: 17870 CASTLETON STREET, SUITE 250 CITY: CITY OF INDUSTRY STATE: CA ZIP: 91748 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Transcode Therapeutics, Inc. CENTRAL INDEX KEY: 0001829635 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 811065054 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6 LIBERTY SQUARE STREET 2: #2382 CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 857-301-6857 MAIL ADDRESS: STREET 1: 6 LIBERTY SQUARE STREET 2: #2382 CITY: BOSTON STATE: MA ZIP: 02109 4 1 tm2417512-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-06-14 0 0001829635 Transcode Therapeutics, Inc. RNAZ 0001693728 Calais Philippe C/O TRANSCODE THERAPEUTICS, INC. 6 LIBERTY SQUARE, #2382 BOSTON MA 02109 1 0 0 0 0 Stock Option (right to buy) 1.20 2024-06-14 4 A 0 70000 0.00 A 2034-06-13 Common Stock 70000 70000 D Fifty percent (50%) of the shares subject to this option vested and became exercisable on January 1, 2024, with the remainder vesting in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. /s/ Thomas A. Fitzgerald, as Attorney-in-Fact 2024-06-18